Login / Signup

Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease.

Fu-Shun YenChii-Min HwaJia-Sin LiuYi-Ling WuKeong ChongChih-Cheng Hsu
Published in: Annals of internal medicine (2024)
National Health Research Institutes, Taiwan.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • cardiovascular disease
  • peritoneal dialysis
  • type diabetes
  • cardiovascular risk factors
  • cardiovascular events
  • breast cancer risk